How do I buy iBio, Inc. Common Stock (IBIO) stock?

Buying iBio, Inc. Common Stock (IBIO) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "IBIO", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy IBIO by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if IBIO is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

iBio, Inc. Common Stock (IBIO) Stock

NASDAQ · IBIO

Trade IBIO

Fundamentals

Market cap

$50.28M

Price / Earnings ratio

-1.8x

Price / Sales ratio

581.0x

Price / Book ratio

0.7x

Return on assets

-42.0%

Dividend amount

$0.00

Dividend yield

0.00%

Source: third-party data provider, as of October 14, 2026

Compare with IBIO

Technical indicators

RSI 14: 19.83
MACD 12/26/9: -0.11
EMA 9 of MACD: -0.08
MACD histogram: -0.03
SMA 50: $1.27; Price below SMA 50
EMA 50: $1.23; Price below EMA 50
SMA 200: $1.78; Price below SMA 200
EMA 200: $1.59; Price below EMA 200

Calculated by Gotrade from daily closing prices, as of October 13, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 1 analyst rating

Strong Sell0

Sell0

Hold0

Buy1

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2025

2026

4800003168001584000

Debt & Balance Sheet

Total assets

Total liabilities

2025

2026

119M78M39M0

Revenue to Profit

2026

$100000.0

Revenue

$0.0

Cost of revenue

$0.0

Gross profit

$0.0

Operating expenses

$-33.0M

Net income

Earnings

No data available

Source: third-party data provider

About iBio, Inc. Common Stock

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

SectorHealthcare

IndustryBiotechnology

Employees23

CEODr. Martin B. Brenner D.V.M., Ph.D.

IPO DateAug 19, 2008

HeadquartersSan Diego, CA

Key Executives

Name	Title	Year Born
Dr. Martin B. Brenner D.V.M., Ph.D.	CEO, Chief Scientific Officer & Director	1970

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2026		+15.1	-29.4	-13.3	+19.5	-7.4	-20.0	-10.6	-6.3	-18.9

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying iBio, Inc. Common Stock (IBIO) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "IBIO", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy IBIO by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in iBio, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, iBio, Inc. Common Stock (IBIO) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track IBIO's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

iBio, Inc. Common Stock (IBIO) Stock

Fundamentals

Compare with IBIO

Recent news

iBio, Inc. (IBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

iBio, Inc. (IBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

IBIO Stock Soars 12% Pre-Market After Company Announces $26 Million Private Placement

IBIO Stock Soars 12% Pre-Market After Company Announces $26 Million Private Placement

3 Healthcare Stocks Short Sellers Are Prescribing for Trouble

3 Healthcare Stocks Short Sellers Are Prescribing for Trouble

Ticking Time Bombs: 3 Healthcare Stocks to Dump Before the Damage Is Done

Ticking Time Bombs: 3 Healthcare Stocks to Dump Before the Damage Is Done

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

iBio, Inc. (IBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

iBio, Inc. (IBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

IBIO Stock Soars 12% Pre-Market After Company Announces $26 Million Private Placement

IBIO Stock Soars 12% Pre-Market After Company Announces $26 Million Private Placement

3 Healthcare Stocks Short Sellers Are Prescribing for Trouble

3 Healthcare Stocks Short Sellers Are Prescribing for Trouble

Ticking Time Bombs: 3 Healthcare Stocks to Dump Before the Damage Is Done

Ticking Time Bombs: 3 Healthcare Stocks to Dump Before the Damage Is Done

3 Millionaire-Maker Biotech Stocks to Buy and Hold Forever

3 Millionaire-Maker Biotech Stocks to Buy and Hold Forever

7 Stocks to Sell as Banks Melt Down

7 Stocks to Sell as Banks Melt Down

7 Penny Stocks to Sell Before They Plunge in 2023

7 Penny Stocks to Sell Before They Plunge in 2023

7 Short-Squeeze Stocks to Sell Before Traders Cash Out

7 Short-Squeeze Stocks to Sell Before Traders Cash Out

3 Healthcare Stocks to Sell Before They Die

3 Healthcare Stocks to Sell Before They Die

About iBio, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Earnings Per Share

Income Statement

Dividend

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade